← Open Payments lookup

BRIAN CRONK: Open Payments

NPI 1760583785 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,127 in 137 payments from 19 companies in 2025. Trend: 2023 $2,419 · 2024 $3,497 · 2025 $3,127

Food & beverage: $3,127
CompanyPaymentsAmount
ABBVIE INC.34$656
Gilead Sciences, Inc.17$483
Janssen Biotech, Inc.14$335
Madrigal Pharmaceuticals7$232
Takeda Pharmaceuticals U.S.A., Inc.9$217
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$204
Ardelyx, Inc.6$194
Regeneron Healthcare Solutions, Inc.7$185
QOL Medical, LLC9$168
GENZYME CORPORATION6$161

Products named: TREMFYA, DUPIXENT, RINVOQ, REZDIFFRA, XIFAXAN, IBSRELA, LINZESS, Sucraid.

Industry payments across CO — which companies pay providers there.